CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer
4 affiliations
- 1Department of Thyroid Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China
- 2Department of Breast and Thyroid Surgery, The Central Hospital of Xiaogan & Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei, 432100, People’s Republic of China
- 3Department of General Surgery (Breast Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China
- 4School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, 430065, People’s Republic of China
Abstract
Background: CD97 is overexpressed in various cancers, but its function and immunoregulatory role in triple-negative breast cancer (TNBC) remain unclear. This study aimed to investigate the expression, function, and potential regulatory mechanisms of CD97 in TNBC.
Methods: CD97 expression, clinical associations, and immune infiltration were evaluated using TCGA, KM Plotter, and GEO bulk, single-cell, and spatial transcriptomic datasets. THP-1-derived M1a/M1b macrophage models with CD97 knockdown or overexpression were used to assess phagocytosis, cytokine secretion, and effects on tumor and endothelial cells. Zinc modulation, NF-κB inhibition, Western blotting, pseudotime analysis, transcription-factor screening, and network analyses were used to explore potential mechanisms.
Results: CD97 was upregulated in TNBC and enriched in M1 macrophages. In a pooled KM Plotter analysis, high CD97 expression was associated with favorable relapse-free survival; however, CD97 was not significantly associated with overall survival in the TCGA-TNBC cohort in univariable or stage-adjusted Firth Cox analyses. In M1a macrophages, CD97 perturbation altered phagocytic activity, tumor-cell apoptosis, intracellular zinc homeostasis, and NF-κB signaling, with pharmacological inhibition supporting NF-κB as a downstream mediator. In M1b macrophages, CD97 knockdown increased, whereas overexpression decreased, MDA-MB-231 migration and invasion in vitro. SPI1 perturbation altered CD97 expression, supporting SPI1 as a potential upstream regulator rather than establishing direct transcriptional control.
Conclusion: CD97 is associated with immune-active features in TNBC and modulates macrophage functions in vitro. Its prognostic relevance appears context- and dataset-dependent, and further in vivo and clinical validation is required before translational application.
Related
- Trichomonas vaginalis-shaped inflammatory microenvironment drives macrophage immune signaling and modulates cervical cancer cell proliferation and migration
- TMEM189/PEDS1 deficiency aggravates MASH progression by promoting FASN-mediated macrophage activation
- Macrophage- or neutrophil-expressed UPP1 drives tumor growth and immune suppression in the tumor microenvironment
- Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
- Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
BibTeX
@article{peng2026cd97,
title = {{CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer}},
author = {Pai Peng and Peng Zhou and Zitao Liu and Haoyuan Shen and Chaohua Hu and Jun Jiang},
journal = {Journal of Inflammation Research},
year = {2026},
month = nov,
doi = {10.2147/jir.s620455},
url = {https://doi.org/10.2147/jir.s620455},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer
AU - Pai Peng
AU - Peng Zhou
AU - Zitao Liu
AU - Haoyuan Shen
AU - Chaohua Hu
AU - Jun Jiang
PY - 2026
DA - 2026/11/05
JO - Journal of Inflammation Research
DO - 10.2147/jir.s620455
UR - https://doi.org/10.2147/jir.s620455
AB - Background: CD97 is overexpressed in various cancers, but its function and immunoregulatory role in triple-negative breast cancer (TNBC) remain unclear. This study aimed to investigate the expression, function, and potential regulatory mechanisms of CD97 in TNBC. Methods: CD97 expression, clinical associations, and immune infiltration were evaluated using TCGA, KM Plotter, and GEO bulk, single-cell, and spatial transcriptomic datasets. THP-1-derived M1a/M1b macrophage models with CD97 knockdown or overexpression were used to assess phagocytosis, cytokine secretion, and effects on tumor and endothelial cells. Zinc modulation, NF-κB inhibition, Western blotting, pseudotime analysis, transcription-factor screening, and network analyses were used to explore potential mechanisms. Results: CD97 was upregulated in TNBC and enriched in M1 macrophages. In a pooled KM Plotter analysis, high CD97 expression was associated with favorable relapse-free survival; however, CD97 was not significantly associated with overall survival in the TCGA-TNBC cohort in univariable or stage-adjusted Firth Cox analyses. In M1a macrophages, CD97 perturbation altered phagocytic activity, tumor-cell apoptosis, intracellular zinc homeostasis, and NF-κB signaling, with pharmacological inhibition supporting NF-κB as a downstream mediator. In M1b macrophages, CD97 knockdown increased, whereas overexpression decreased, MDA-MB-231 migration and invasion in vitro. SPI1 perturbation altered CD97 expression, supporting SPI1 as a potential upstream regulator rather than establishing direct transcriptional control. Conclusion: CD97 is associated with immune-active features in TNBC and modulates macrophage functions in vitro. Its prognostic relevance appears context- and dataset-dependent, and further in vivo and clinical validation is required before translational application.
SN - 1178-7031
ER -